Analytics
Viome has adapted its technology to search for the presence of oral squamous cell carcinoma and oropharyngeal cancer in users’ saliva samples.
Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.
The new joint venture will leverage AI technology to create digital healthcare solutions for the employer and consumer markets.
The new algorithm allows for automated analysis of CT scans of patients with the condition.
The Oxehealth Vital Signs system is installed in a patient's hospital room, where it can spot-measure pulse, heart, respiratory and breathing rates with no physical contact.
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.
The system uses heatmaps to make AI decisions transparent to clinicians.
New data published in JMIR outlines encouraging results from a modified version of the text-based chatbot app.
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.